Atlas Trials

International Trial of the Efficacy and Safety of BCD-100 in Patients With Melanoma

Clinical trial NCT03269565 · UNKNOWN

Trial details

NCT number
NCT03269565
Sponsor
Biocad
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2017-08-31
Primary completion
2018-08-29
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.